SCRS’s Jimmy Bechtel on why Bring-Your-Own-Tech is both a protest and a performance differentiator, and what the industry needs to do about it.
- HTA, Digital Twins, And Building Clinical Tech That Lasts
- Real-World Evidence And Wearables Are Reshaping Trial Tech
- Navigating Elsa's AI Transition: Practical Guidance To Safeguard Confidential Information (Part 3)
- HEOR, AI, And The Future Of Clinical Trial Technology
- AI Amplifies Capabilities But Also Risks: Learn The Legal Consequences Of AI In Clinical Research
- Is It Time To Replace RECIST — Or Just Add AI?
- Clinical Research Has System Sprawl Problem
- How Clinical Trial Sites Must Adapt To The Predictive Analytics Era
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
How Can Sponsors Enable Research-Naïve Clinical Trial Sites
Clinical trial capacity in the U.S. is heavily concentrated, and technology is playing a critical role in enabling a shift to expanding site networks and alleviating the burden on sites and patients.
-
Site And Sponsor Harmonization For Speedy Startups, Monitoring
Now more than ever, stakeholders need harmony among their disparate systems — and that starts with the right organizational mindset: a culture of connectivity. Here’s what our experts recommend.
-
Paper vs. eCOA: Hard Calculations For Easy Decisions
Sticker prices often guide purchases, but there's a broader perspective that encompasses total cost. Use this calculator to compare prices of paper COAs or eCOAs, including ePROs, eDiaries, and eClinROs.
-
12 Items Auditors Look For When Reviewing An Investigator Site File
Maintaining complete, compliant documentation on top of managing the complex processes and interactions of clinical trial conduct can be challenging. Explore twelve items to help you prepare your ISF for an audit.
-
Agentic AI Is Transforming Life Sciences Discovery And Operations
73% of pharma companies are planning or deploying agentic AI. Discover who’s leading and how intelligent agents are transforming R&D.
-
Focusing On Patient-Reported Outcome Measures And eConsent
Learn how digital solutions can contribute to a more participant-centered approach and potentially enhance the regulatory utility of PRO data while improving the overall quality and efficiency of oncology trials.
-
A Leading Academic Medical Center Monitors Newly Diagnosed Myeloma Patients
Learn how eCOA helped to motivate patients and increased engagement around experiences outside of the clinical setting, which otherwise may have gone unmentioned.
-
Automated Trial Monitoring Workflows Make A Lean Team More Efficient
A pharmaceutical therapy developer was looking to automate reports, confirmation letters, and follow-up letters. See what happened when they adopted a cloud-based solution for end-to-end trial management.
-
Frequently Asked Questions About IRMS MAX
Improve your information access and capabilities with the definitive gold standard of medical information systems.
-
How To Reduce Eligibility Risk And Prevent Protocol Deviations
Eliminate enrollment-based protocol deviations and align with the latest FDA guidance by implementing a centralized, technology-enabled eligibility review to safeguard trial integrity.
RECENT NEWSLETTERS
- 04.23.26 -- Smarter Trials Start Here: Data Quality, AI & Infrastructure Insights
- 04.16.26 -- 5 eTMF Questions, Agentic AI's Real Impact On Clinical Trials & More
- 04.09.26 -- AI In Clinical Trials: Recruitment, eCOA Risks & Data
- 04.04.26 -- Your March Briefing: The Best In Clinical Trial Tech
- 04.02.26 -- AI Is Reshaping Clinical Trials: Here's How to Keep Up